Europe

This archive covers progress stories and milestones from across Europe, spanning health, climate policy, social equity, and scientific research. From small-nation experiments to E.U.-wide initiatives, these reports highlight what is working and why.

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

Danish scientists design new form of insulin that automatically switches itself on and off

By / / Good News For Humankind

Smart insulin that reads blood sugar in real time and adjusts its own activity has cleared a major hurdle in animal trials, according to Danish researchers publishing in Nature. The molecule switches on when glucose climbs and powers down as levels normalize, mimicking the feedback loop of a healthy pancreas. That matters because conventional insulin can overshoot and trigger dangerously low blood sugar, a side effect that endangers people living with diabetes every day. Scientists have chased this idea for more than 40 years, and earlier candidates kept stumbling in living bodies. For the more than 500 million people worldwide managing diabetes, an insulin that doses itself would be a quiet revolution — bringing daily care closer to how the body was meant to work.

Insulin pens, for article on duodenal mucosal resurfacing

New treatment eliminates insulin for 86% of patients in early trials

By / / Good News For Humankind

A one-hour outpatient procedure helped 12 of 14 Type 2 diabetes patients stop using insulin entirely and stay off it for a full year. Researchers at Amsterdam University Medical Center used a catheter to deliver gentle electrical pulses to the lining of the small intestine, prompting the tissue to regenerate and apparently restoring the body’s natural insulin response. By comparison, the widely used medication semaglutide alone helps only about one in five patients discontinue insulin. The team calls the approach “disease-modifying” because it targets the root cause rather than the symptoms, and a larger randomized trial is now in the works. If the results hold, it could reshape how a condition affecting hundreds of millions worldwide is treated.

Ovarian and Cervical Cancer Awareness. a Teal Ribbon, for article on cervical cancer treatment

New cervical cancer treatment regime ‘cuts risk of dying from disease by 40%’

By / / Good News For Humankind

Cervical cancer treatment just took its biggest leap in 25 years, and the breakthrough comes from a surprisingly simple idea: changing the timing. In a trial spanning the U.K., Mexico, India, Italy, and Brazil, women who received a short course of chemotherapy before standard chemoradiation were 40% less likely to die from the disease. Even better, the drugs involved are already approved, affordable, and widely available — meaning hospitals could adopt this approach without waiting on a new wonder drug. For the hundreds of thousands of women diagnosed each year, especially in lower-income countries where cervical cancer hits hardest, it’s a rare kind of medical good news: a major gain that’s actually within reach.

image for article on ovarian cancer prevention vaccine

Scientists in the U.K. developing world’s first vaccine to prevent ovarian cancer

By / / Good News For Humankind

OvarianVax, in development at the University of Oxford, has just received up to £600,000 from Cancer Research U.K. to pursue the world’s first vaccine designed to prevent ovarian cancer before it begins. The idea is to train the immune system to recognize over 100 proteins found on early-stage ovarian cancer cells, then destroy those cells before they can spread. For women carrying BRCA gene mutations, who currently face the wrenching choice of preventive surgery that ends fertility and triggers early menopause, a vaccine could transform what’s possible. It’s still early days, with lab work and clinical trials ahead, but the project signals a real shift in cancer research: moving from treatment toward prevention, and giving high-risk women better options worldwide.

A loggerhead sea turtle crawling on a sandy beach for an article about loggerhead sea turtle nests in Greece, for article on loggerhead sea turtle nests

Greece records more than 10,000 loggerhead sea turtle nests in a single year

By / / Good News For Humankind

Loggerhead sea turtle nests in Greece have surpassed 10,000 in a single year for the first time in recorded history, nearly doubling the previous annual average of 5,000 to 7,000. The milestone reflects decades of sustained conservation work by organizations like Archelon and Medasset, whose efforts to protect nesting beaches, regulate tourism, and deploy monitoring technology are now yielding measurable results. Greece hosts roughly 60% of all Mediterranean loggerhead nests, making this recovery regionally significant. Conservationists warn, however, that mounting tourism pressure and climate change mean the gains remain fragile and enforcement of protective measures must continue.

A busy highway filled with electric vehicles charging at roadside stations for an article about global EV fleet milestone, for article on electric vehicles Norway

Norway becomes world’s first country to have more fully electric cars than gas cars

By / / Good News For Humankind

Electric vehicles in Norway have officially overtaken gasoline cars on the road, a first for any country. Out of roughly 2.87 million passenger vehicles nationwide, battery electric cars now lead — a stunning flip from 2004, when just 1,000 EVs shared the road with 1.6 million gas cars. The shift came not through bans but through years of steady incentives: tax breaks, cheaper tolls, and accessible charging that made going electric the obvious choice. Diesel could be the next domino to fall, possibly as soon as 2026. Norway’s quiet, two-decade transformation offers the rest of the world a hopeful blueprint — proof that a car-loving country really can rewire its roads within a single generation.

The Hague waterfront and buildings, for article on fossil fuel ad ban

The Hague becomes world’s first city to pass law banning fossil fuel-related ads

By / / Good News For Humankind

The Hague has just become the first city in the world to legally ban fossil fuel advertising, prohibiting promotions for petrol, diesel, aviation, and cruise ships across billboards, bus shelters, and other outdoor spaces starting in 2025. The ordinance took two years to pass and arrived only after voluntary agreements collapsed, with ad operators simply refusing to comply. Researchers compare it to tobacco advertising bans: the point isn’t just to stop one billboard, but to chip away at the sense that high-carbon choices are the normal default. Cities like Toronto, Graz, and Amsterdam have been waiting for someone to go first, and now they have a working legal template. It’s a small but meaningful reminder that cities don’t have to wait for national governments to start reshaping the climate conversation.

Helsinki, for article on air-to-water heat pump

World’s largest air-to-water heat pump to warm 30,000 homes in Finland

By / / Good News For Humankind

Helsinki’s new heat pump can warm 30,000 homes on renewable electricity alone, even when winter temperatures drop to -4°F. Built by MAN Energy Solutions for Finnish utility Helen Oy, it’s the largest air-to-water heat pump in the world, and it uses carbon dioxide as its refrigerant instead of the harmful gases most pumps rely on. Once it switches on for the 2026–2027 heating season, it’s expected to cut around 26,000 tonnes of CO2 each year compared to fossil-fueled heating. Cold cities everywhere have been waiting for proof that district heating can go fully renewable without sacrificing reliability through deep winters. If Helsinki’s machine delivers, it offers a blueprint Scandinavia, Central Europe, and beyond can actually follow.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

World’s first mRNA lung cancer vaccine enters human trials in seven countries

By / / Good News For Humankind

A landmark mRNA lung cancer vaccine is now being tested in human patients for the first time, marking a historic milestone in cancer treatment. BNT116, developed by BioNTech, uses the same messenger RNA technology behind COVID-19 vaccines to train the immune system to recognize and destroy non-small cell lung cancer cells. The phase 1 trial spans 34 sites across seven countries, with roughly 130 patients enrolled. Unlike chemotherapy, this approach targets only tumor cells, potentially offering a more precise and lasting defense against the world’s deadliest cancer, which kills 1.8 million people annually.

Big Ben with bridge over Thames and flag of England against blue sky in London, for article on women in Parliament

British voters elect record number of women to Parliament

By / / Good News For Humankind

Britain’s 2024 general election sent at least 242 women to the House of Commons, the most in the chamber’s history and a jump from the previous record of 220 set in 2019. That brings female representation past 37% of the 650-seat lower house, climbing steadily from 30% just a decade ago. Behind the number is decades of deliberate work by parties to recruit women candidates, alongside shifting expectations about who belongs in power. Research suggests that once women hold more than a token share of seats, legislatures tend to take up health, education, and family policy with fresh seriousness. It’s a reminder that representation, once it reaches a critical mass, starts reshaping what democracies pay attention to.